Molecular mobility‐based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions

Guo, 2000, Physical characteristics and chemical degradation of amorphous quinapril hydrochloride, J Pharm Sci, 89, 128, 10.1002/(SICI)1520-6017(200001)89:1<128::AID-JPS13>3.0.CO;2-Z

Shamblin, 1999, Characterization of the time scales of molecular motion in pharmaceutically important glasses, J Phys Chem B, 103, 4113, 10.1021/jp983964+

Hancock, 1997, Characteristics and significance of the amorphous state in pharmaceutical systems, J Pharm Sci, 86, 1, 10.1021/js9601896

Ngai, 2000, Flow, diffusion and crystallization of supercooled liquid: Revisited, J Chem Phys, 112, 1887, 10.1063/1.480752

Saleki-Gerhardt, 1994, Non-isothermal and isothermal crystallization of sucrose from the amorphous state, Pharm Res, 11, 1166, 10.1023/A:1018945117471

Rodriguez-Hornedo, 1999, Significance of controlling crystallization mechanism and kinetics in pharmaceutical systems, J Pharm Sci, 88, 651, 10.1021/js980490h

Aso, 2001, Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by 13C NMR relaxation time and the relaxation time obtained from the heating rate dependence of Tg, J Pharm Sci, 89, 128

Hodge, 1987, Effects of annealing and prior history on enthalpy relaxation in glassy polymers. 6. Adam-Gibbs formulation of nonlinearity, Macromolecules, 20, 2897, 10.1021/ma00177a044

Yoshioka, 1995, Inhibition of indomethacin crystallization in Poly(vinylpyrrolidone) coprecipitate, J Pharm Sci, 84, 983, 10.1002/jps.2600840814

Matsumoto, 1999, Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinyl pyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization, Pharm Res, 16, 1722, 10.1023/A:1018906132279

Shamblin, 1999, The effect of absorbed water on the properties of amorphous mixtures containing sucrose, Pharm Res, 16, 1119, 10.1023/A:1018960405504

Zeng, 2000, Effects of molecular weight of polyvinylpyrrolidone on the glass transition temperature and crystallization of co-lyophilized sucrose, Int J Pharm, 218, 63, 10.1016/S0378-5173(01)00613-5

Taylor, 1997, Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions, Pharm Res, 14, 1691, 10.1023/A:1012167410376

Khougaz, 2000, Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymer, J Pharm Sci, 89, 1325, 10.1002/1520-6017(200010)89:10<1325::AID-JPS10>3.0.CO;2-5

Takeuchi, 2000, Temperature- and moisture-induced crystallization of amorphous lactose on composite particles with sodium alginate prepared by spray-drying, Pharm Dev Technol, 5, 355, 10.1081/PDT-100100551

Hirayama, 1994, Effect of 2-hydroxy-β-cyclodextrin on crystllization and polymorphic transition of nifedipine in solid state, Pharm Res, 11, 1766, 10.1023/A:1018971501909

Uekama, 1992, Inhibitory effect of 2-hydroxypropyl-β-cyclodextrin on crystal-growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone K-30, J Pharm Pharmacol, 44, 73, 10.1111/j.2042-7158.1992.tb03564.x

Kato, 1978, Relationship between polymorphism and bioavailability of phenobarbital, Yakugaku Zasshi, 98, 639, 10.1248/yakushi1947.98.5_639

Putnam, 1993, J Chem Thermodyn, 25, 607, 10.1006/jcht.1993.1055

Andronis, 1998, The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity, Pharm Res, 15, 835, 10.1023/A:1011960112116

Tong, 1999, Solid-state characteristics of amorphous sodium indomethacin relative to its free acid, Pharm Res, 16, 1186, 10.1023/A:1018985110956

Guinot, 1999, The use of MTDSC to assess the amorphous phase content of micronised drug substance, Int J Pharm, 192, 63, 10.1016/S0378-5173(99)00273-2

Aso, 2000, Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and 1H NMR relaxation times, J Pharm Sci, 89, 408, 10.1002/(SICI)1520-6017(200003)89:3<408::AID-JPS11>3.0.CO;2-#

Shamblin, 1998, Enthalpy relaxation in binary amorphous miztures containing sucrose, Pharm Res, 15, 1828, 10.1023/A:1011997721086

Andronis, 2000, Crystal nucleation and growth of indomethacin polymorphs from the amorphous state, J Non-cryst Solids, 271, 236, 10.1016/S0022-3093(00)00107-1